|
Synonyms: compound 5 [PMID: 29902723]
Compound class:
Synthetic organic
Comment: PSB-CB5 is reported as a GPR18 antagonist [1]. It achieves partial inhibition (60%) of β-arrestin recruitment by tetrahydrocannabinol (THC)-activated human GPR18.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| PSB-CB5 is selective for GPR18 compared to GPR55 and the CB1 cannabinoid receptor, but exhibits low affinity (μM) binding to the CB2 receptor [1]. |
| Selectivity at GPCRs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||